Special Issue "New Frontiers in Treatment for Gynecologic Cancers"

A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Gynecologic Oncology".

Deadline for manuscript submissions: 31 January 2022.

Special Issue Editors

Dr. Laurie M. Elit
E-Mail Website
Guest Editor
Professor Emeritus, Department of Gynecology, Division Gynecology Oncology, McMaster University, Hamilton, ON, Canada
Interests: gynecologic cancers or precancerous; health services research; evidence based medicine
Dr. Taymaa May
E-Mail Website
Co-Guest Editor
University Health Network, Associate professor, Department Obstetrics and Gynecology, University of Toronto, Toronto, ON, Canada
Interests: serum biobanking; surgical cytoreduction; fertility preservation

Special Issue Information

Dear Colleagues,

For the longest time, the management of gynecologic malignancies was very streamlined, with few options and mediocre outcomes, especially for those with advanced or recurrent disease. In the recent past, however, there has been a rapid advancement in care, including methods of surgical access to the malignancy, molecular diagnosis, and classification of disease, personal medicine therapeutic options and methods of radiation therapy, and combinations thereof. We invite researchers to address one of these topics related to malignancies of the ovary/fallopian tube, uterus, cervix/vagina/vulvar (lower genital tract), or gestational trophoblastic neoplasm.

Dr. Laurie M. Elit
Dr. Taymaa May
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • gynecologic cancers (ovary/fallopian tube, uterus, cervix, vagina, vulva, GTN)
  • immune inhibitors
  • PARP inhibitors
  • ERAS
  • minimally invasive surgery

Published Papers

This special issue is now open for submission.
Back to TopTop